FDA Inspection 751470 — AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP — FEI 1825662

The FDA completed an inspection of AstraZeneca Pharmaceuticals LP on October 28, 2011 in Mount Vernon, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 28, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mount Vernon, IN (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
358321 CFR 211.110(a)Written in-process control procedures